Skip to main content

Tandutinib

LKT-T0152

Axxora Marketplace
  • LKT-T0152-M001   —   1 mg
  • LKT-T0152-M005   —   5 mg
    $441.00
  • LKT-T0152-M025   —   25 mg
    $1,463.00

A piperazinyl quinazoline receptor tyrosine kinase inhibitor with antineoplastic activity. Tandutinib inhibits the autophosphorylation of FLT3 (FMS-Like Tyrosine kinase-3), c-KIT and PDGF (platelet-derived growth factor) receptor tyrosine kinases, thereby inhibiting cellular proliferation and inducing apoptosis.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account

Regulatory Status

RUO – Research Use Only